Literature DB >> 24381964

Careful use of science to advance the debate on the UK Cancer Drugs Fund.

Darius N Lakdawalla1, Anupam B Jena2, Jason N Doctor1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24381964      PMCID： PMC3887550          DOI： 10.1001/jama.2013.282839

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Are regional variations in end-of-life care intensity explained by patient preferences?: A Study of the US Medicare Population.

Authors:  Amber E Barnato; M Brooke Herndon; Denise L Anthony; Patricia M Gallagher; Jonathan S Skinner; Julie P W Bynum; Elliott S Fisher
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

2.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

3.  How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies.

Authors:  Darius N Lakdawalla; John A Romley; Yuri Sanchez; J Ross Maclean; John R Penrod; Tomas Philipson
Journal:  Health Aff (Millwood)       Date:  2012-04       Impact factor: 6.301

4.  Societal views on NICE, cancer drugs fund and value-based pricing criteria for prioritising medicines: a cross-sectional survey of 4118 adults in Great Britain.

Authors:  Warren G Linley; Dyfrig A Hughes
Journal:  Health Econ       Date:  2012-09-07       Impact factor: 3.046

Review 5.  Aggressiveness of cancer care near the end of life: is it a quality-of-care issue?

Authors:  Craig C Earle; Mary Beth Landrum; Jeffrey M Souza; Bridget A Neville; Jane C Weeks; John Z Ayanian
Journal:  J Clin Oncol       Date:  2008-08-10       Impact factor: 44.544

6.  Risk attitude in gambles with years of life: empirical support for prospect theory.

Authors:  L C Verhoef; A F de Haan; W A van Daal
Journal:  Med Decis Making       Date:  1994 Apr-Jun       Impact factor: 2.583

7.  Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.

Authors:  M L Slevin; L Stubbs; H J Plant; P Wilson; W M Gregory; P J Armes; S M Downer
Journal:  BMJ       Date:  1990-06-02
  7 in total
  1 in total

1.  Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population.

Authors:  Tatiana Dilla; Luís Lizan; Silvia Paz; Pilar Garrido; Cristina Avendaño; Juan J Cruz-Hernández; Javier Espinosa; José A Sacristán
Journal:  Patient Prefer Adherence       Date:  2015-12-18       Impact factor: 2.711
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.